Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative precision diagnostic agents and radiopharmaceutical agents. NAVB is actively developing four radiopharmaceutical agent platforms: Lymphoseek®, 4694, CFT and RIGScan™. The company’s strategy is to bring to market novel radiopharmaceutical agents and advance its pipeline through acquisitions, global partnering and commercialization efforts. For more information visit the company’s Web site at www.navidea.com.
Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
Let us hear your thoughts below: